Committee on Kidney Disease - (C-KD)

 Membership

Aim

To promote, support and co-ordinate international activities related to laboratory testing in Kidney Diseases (KD).

Objectives

1. Obtain information on the current state of coordinated national and international activity in the area of pathology testing in KD.
2. Assess current best practice in KD-related testing.
3. Assess best practice for implementation of best practice for KD-related testing.
4. Provide assistance where required for member organizations and others in planning and implementing KD testing policies and guidelines.
5. Identify other relevant areas of laboratory related issues in KD.
6. Harmonize the definition of Acute Kidney Disease in Collaboration with KDIGO, ASN, ERA and AKIN network.
7. Assess the current status of conventional biomarkers in the diagnosis and or monitoring of AKD
8. Explore the current research in order to determine the possibility of new biomarkers to be implemented in the diagnosis of AKD and in the revision of its definition
9. Identify other areas (or special clinical scenarios) that kidney is involved and the need to define AKD in these cases.

Delivery

1. A report on the current status of guidelines on CKD pathology testing.
2. A review of the items covered in CKD pathology testing guidelines.
3. A review of best practice processes for implementing change in KD-related pathology testing.
4. An assessment of areas of likely relevant future activity in KD testing.

Accountability

The Committee is accountable to the EMD EC through the Chair.

List of Corresponding Members, nominated by National Societies